Events

XIV International Pharmaceutical Licensing Symposium

Event Details

  • Location: Montreux, Switzerland
  • Dates: Wednesday 19th September to Friday 21st September 2018
  • Price:
    (Non-Members: €1025)

We are delighted that Vas Narasimhan, CEO at Novartis, will deliver the keynote presentation to open the XIV IPLS on 20th September. Details of all speakers participating at the event can be found here; Full Speaker Details.

The XIV IPLS that will take place in the stunning surroundings of Montreux, Switzerland, starting in the afternoon of Wednesday 19th to Friday 21st September 2018. The event begins on 19th September with the opportunity to hold pre-arranged partnering meetings (an online partnering system is available to contact all participants and make appointments) prior to the evening networking reception held in Funky Claude’s Jazz Bar.

Montreux is a beautiful one hour and ten minute train journey direct from Geneva Airport, with fantastic scenery as the train skirts around the edge of Lake Geneva.

Participants now have the option of joining one of two additional training workshops being run in parallel to the one-to-one meeting time on Wednesday from 3pm-6pm. The 3-hour training workshops can be booked online at a cost of €100 per person, and will cover:

Workshop A – Financial Evaluation of Licensing Deals

Workshop B – Alliance Management

Transport

Train tickets for journeys direct from Geneva Airport to Monteux should be purchased in advance from the SBB website, www.sbb.ch/en, to take advantage of low ticket prices from CHF18 per journey.

Following the success of the online partnering system used during the 2017 event in Madrid, the programme will once again commence on Wednesday afternoon for pre-arranged one-to-one meetings prior the evening drinks reception overlooking Lake Geneva. Partnering and networking will be ongoing throughout the event, with a managed and dedicated one-to-one meeting room available, with extended breaks and a gala dinner on Thursday evening.

The programme will feature 5 sessions, including  Deal Case Studies from across the industry (Medical Devices, Biotech, Big Pharma), Regulatory Updates, Opportunities and Market Entry in China, plus the regular look at the Deal Landscape including views and analysis from Evaluate.

Full Speaker Details

Event Sponsors

Event Schedule

Wednesday 19th September

3pm - 6pm Pre-Arranged One-to-One Meetings
3pm-6pm Optional Training Workshops (additional €100 per person)
Workshop A Financial Evaluation of Licensing Deals
KLAUS MALECK
CEO, Tetec
Workshop B Alliance Management
ANTHONY A. HOERNING
Strategic Transactions Advisory
6pm - 8pm Welcome Networking Reception

Thursday 20th September

9am - 9.30am Registration
Session A NEW OPPORTUNITIES FOR BD IN A CHANGING WORLD
9.30am - 10am Switzerland - an International Hub for Europe
VAS NARASIMHAN
CEO, Novartis
10am-10.30am Brexit and its Consequences for the Pharmaceutical Industry
MARTIN WEISER
Director General, B.A.H. (German Medicines Manufacturers' Association)
10.30am - 11am Business Opportunities Opening in China
HELEN CHEN
Managing Director and Partner, Head of China Practice, L.E.K. Consulting
11am 11.30am Market Entry in China
RONG HUI GAO
Business Development & Licensing, Merger & Acquisitions, Managing Director, G-Med Consulting Ltd
11.30am - 12pm BREAK
SESSION B NEWS FROM THE REGULATORY & MARKET ACCESS ENVIRONMENT AND THEIR IMPACT ON BD
12pm -12.30pm Market Access Challenges
PIERFRANCESCO RUFFO
Head Market Access, Helsinn Healthcare Switzerland
12.30pm - 1pm Regulatory Updates on Current Changes and Impact on BD
SARAH COWLISHAW
Associate, Covington & Burling
1pm - 2pm LUNCH
SESSION C LESSONS FROM REAL WORLD CASE STUDIES
2pm - 2.30pm Food Supplements
ANDREA COSTA
President, FederSalus (Italy)
2.30pm-3pm Biotech and Big Pharma Deals
DIDIER LANDAIS
Global Head of Licensing, Servier Monde
3pm - 3.30pm Big Pharma to Big Pharma Deals
ANTHONY GEMMELL
Senior Director, EMEA Network New Ventures & Transactions, Johnson & Johnson Innovation
3.30pm - 4pm Looking Back at the Top Deals - Which Were Truly Successful
ELENA COLUCCELLI-GUERIN Managing Director, Investment Banking, Healthcare, BNP Paribas
&
LUISA HECTOR
Pharma Analyst, Exane BNP Paribas
4pm - 6pm Pre-Arranged One-to-One Meetings
7pm - 10pm Networking Reception and Gala Dinner

Friday 21st September

SESSION D ANALYSING THE HOTTEST DEAL EVOLUTIONS AND NEW DYNAMICS
9am - 9.30am How the Pharma Market is Evolving
9.30am - 10am Current Key Deal Making Trends in Oncology
PETER LANG
Managing Director Life Science, Navigant
10am - 10.30am Joint Development Agreements and Creative Deal Structures
10.30am - 11am BREAK
SESSION E BACK TO THE FUTURE: HOW CAN WE BUILD A FUTURE WITHOUT LOSING OUR PAST?
11am - 11.30am Designing the Optimal Exit Strategy: IPO, M&A or Dual Track? Featuring Case Studies from Leading Biotech Players in Benelux: Argenx, Galapagos, Ablynx & Ogeda
NADINE MAALOUF
Executive Director, Corporate Finance, Life Sciences & Healthcare, Kempen
11.30am - 12pm Transformational Deals - Deals Which Changed the Business
12pm - 12.30pm Pharma Deals: Which Trends are Driving the Future of Deal Making?
SARAH RICKWOOD
Vice President, European Thought Leadership, IQVIA
12.30pm - 2pm LUNCH AND CLOSE

Venue & Accommodation

Full Venue Address

Fairmont Le Montreux Palace
Avenue Claude Nobs 2
CH-1820 Montreux
Montreux
Switzerland

View Map

Accommodation Details

Accommodation Details

BOOK DISCOUNTED HOTEL RATES HERE

A discounted rate of CHF299 bed & breakfast, per night, is available at the Fairmont Le Montreux Palace for all attendees. This rate can be booked directly with the hotel using the link below. These rates are for Weds 19th – Fri 21st September. For any additional nights or further information please contact acollins@ngaevents.co.uk

BOOK DISCOUNTED HOTEL RATES HERE